Discounted Cash Flow (DCF) Analysis Levered

Biomerica, Inc. (BMRA)

$0.9001

-0.02 (-2.18%)
All numbers are in Millions, Currency in USD
Stock DCF: 4,345.41 | 0.9001 | undervalue

Free Cash Flow

Year
A/P
2019
Actual
2020
Actual
2021
Actual
2022
Actual
2023
Actual
2024
Projected
2025
Projected
2026
Projected
2027
Projected
2028
Projected
Revenue 5.206.697.2018.875.347.039.2612.1916.0521.13
Revenue (%)
Operating Cash Flow -2.24-4.30-5.25-0.48-5.47-4.01-5.28-6.96-9.16-12.06
Operating Cash Flow (%)
Capital Expenditure -0.17-0.12-0.30-0.17-0.08-0.16-0.21-0.28-0.37-0.49
Capital Expenditure (%)
Free Cash Flow -2.42-4.42-5.55-0.65-5.55-4.17-5.50-7.24-9.53-12.55

Weighted Average Cost Of Capital

Share price $ 0.9,001
Beta -0.618
Diluted Shares Outstanding 13.35
Cost of Debt
Tax Rate -0.72
After-tax Cost of Debt 5.00%
Risk-Free Rate
Market Risk Premium
Cost of Equity 1.709
Total Debt 1.08
Total Equity 12.01
Total Capital 13.09
Debt Weighting 8.26
Equity Weighting 91.74
Wacc

Build Up Free Cash Flow

Year
A/P
2019
Actual
2020
Actual
2021
Actual
2022
Actual
2023
Actual
2024
Projected
2025
Projected
2026
Projected
2027
Projected
2028
Projected
Revenue 5.206.697.2018.875.347.039.2612.1916.0521.13
Operating Cash Flow -2.24-4.30-5.25-0.48-5.47-4.01-5.28-6.96-9.16-12.06
Capital Expenditure -0.17-0.12-0.30-0.17-0.08-0.16-0.21-0.28-0.37-0.49
Free Cash Flow -2.42-4.42-5.55-0.65-5.55-4.17-5.50-7.24-9.53-12.55
WACC
PV LFCF -4.09-5.29-6.82-8.81-11.38
SUM PV LFCF -36.39

Terminal Value

Growth in perpetuity method:
Long-term growth rate
WACC (%) 1.98
Free cash flow (t + 1) -12.80
Terminal Value 63,996.28
Present Value of Terminal Value 58,020.26

Intrinsic Value

Enterprise Value 57,983.87
Net Debt -8.64
Equity Value 57,992.51
Shares Outstanding 13.35
Equity Value Per Share 4,345.41